TY  - JOUR
AU  - Meca-Lallana, J. E.
AU  - Oreja-Guevara, C.
AU  - Munoz, D.
AU  - Olascoaga, J.
AU  - Pato, A.
AU  - Ramio-Torrenta, L.
AU  - Meca-Lallana, V.
AU  - Hernandez, M. A.
AU  - Marzo, M. E.
AU  - Alvarez- Cermeno, J. C.
AU  - Rodriguez-Antigueedad, A.
AU  - Montalban, X.
AU  - Fernandez, O.
AU  - Spanish Gilenya Registry Investi
PY  - 2021
DO  - 10.1371/journal.pone.0258437
SN  - 1932-6203
UR  - https://hdl.handle.net/10668/28225
T2  - Plos one
AB  - Objective To describe the profile of patients with multiple sclerosis (MS) treated with fingolimod in Spain and to assess the effectiveness and safety of fingolimod after 4 years of inclusion in the Spanish Gilenya Registry.Methods An observational,...
LA  - en
PB  - Public library science
KW  - Real-world evidence
KW  - Clinical-practice
KW  - Oral fingolimod
KW  - Efficacy
KW  - Persistence
KW  - Experience
KW  - Therapy
KW  - Trial
KW  - Rwe
TI  - Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
TY  - research article
VL  - 16
ER  -